Analyst firms · BofA Securities · REGN
BofA Securities REGN price target and rating history
Regeneron Pharmaceuticals Inc. (REGN) · Health Care
BofA Securities rates Regeneron Pharmaceuticals Inc. (REGN) Buy with a $860 price target, as of its latest action on Jan 7, 2026. It has published 3 rating actions on REGN since January 2022, including 1 upgrade and 1 downgrade. Across 9 firms with a REGN price target in the last 12 months, the median target is $798. BofA Securities's $860 is 8% above that.
- Current rating
- Buy
- Price target
- $860
- Median target, all firms
- $798
- Actions on REGN
- 3
BofA Securities price target on REGN
Every BofA Securities rating on REGN
- Jan 7, 2026
- Dec 10, 2024
- Jan 5, 2022
How other firms rate REGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $850 | Oct 1, 2026 |
| Citigroup | Neutral | $700 | May 18, 2026 |
| Leerink Partners | Market Perform | $641 | May 18, 2026 |
| Piper Sandler | Overweight | $875 | Mar 31, 2026 |
| Barclays | Overweight | $923 | Mar 6, 2026 |
| BofA Securities | Buy | $860 | Jan 7, 2026 |
| Morgan Stanley | Equal-Weight | $767 | Dec 3, 2025 |
| Truist Securities | Buy | $798 | Nov 24, 2025 |
| HSBC | Buy | $255 | Nov 24, 2025 |
Questions about BofA Securities and REGN
- What is BofA Securities's price target for REGN?
- BofA Securities's latest stated price target for Regeneron Pharmaceuticals Inc. (REGN) is $860, from its action on Jan 7, 2026.
- What is BofA Securities's rating on REGN?
- BofA Securities rates REGN Buy, a bullish rating, as of Jan 7, 2026.
- When did BofA Securities last change its view on REGN?
- On Jan 7, 2026, BofA Securities upgrades to Buy from Underperform, price target $860.
- How does BofA Securities's REGN target compare with other analysts?
- Across 9 firms with a REGN price target in the last 12 months, the median target is $798. BofA Securities's $860 is 8% above that.
More REGN rating histories
- Citigroup3
- Leerink Partners9
- Morgan Stanley7
- Truist Securities3
- Bernstein3
- Raymond James3
- Oppenheimer3
- Jefferies3
- The Benchmark Company3
- H.C. Wainwright5
All BofA Securities ratingsREGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.